| Mukti Kulkarni, MD | |
|
279 Lincoln St, Worcester, MA 01605-2120 | |
| (508) 334-1000 | |
| Not Available |
| Full Name | Mukti Kulkarni |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 279 Lincoln St, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821355595 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Umass Memorial Medical Center/university Campus | Worcester, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Umass Memorial Medical Group Inc | 4284539891 | 1889 |
News Archive
The "demands imposed by the retirement of millions of baby boomers will consume the federal budget and blight the prospects of the next generations" without efforts to address problems with the long-term financial stability of Medicare and other entitlement programs, columnist David Broder writes in the Washington Post.
A recent paper published in the scientific journal Cell gives an unprecedented insight into the metabolic interactions that occur throughout the body over 24 hours.
Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, is pleased to announce the US Food and Drug Administration clearance of QUANTA Lite Calprotectin Extended Range, an assay which aids in the diagnosis of Inflammatory Bowel Disease (IBD), and can help differentiate IBD from Irritable Bowel Syndrome (IBS).
PAREXEL Consulting, a business unit of PAREXEL International and leading global life sciences consultancy serving the biopharmaceutical and medical device industries, today released two new white papers from leading biosimilar experts that provide key insights into emerging areas of biosimilar development.
New preclinical work by a team of researchers from Roswell Park Comprehensive Cancer Center's Transplant and Cellular Therapy Program suggests that the risk of developing acute graft vs. host disease during allogeneic blood/marrow transplant - a potentially curative treatment for selected patients with hematologic disorders -; can be decreased using an existing class of drugs called beta adrenergic agonists.
› Verified 8 days ago
| Entity Name | Umass Memorial Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760445373 PECOS PAC ID: 4284539891 Enrollment ID: O20040113000267 |
News Archive
The "demands imposed by the retirement of millions of baby boomers will consume the federal budget and blight the prospects of the next generations" without efforts to address problems with the long-term financial stability of Medicare and other entitlement programs, columnist David Broder writes in the Washington Post.
A recent paper published in the scientific journal Cell gives an unprecedented insight into the metabolic interactions that occur throughout the body over 24 hours.
Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, is pleased to announce the US Food and Drug Administration clearance of QUANTA Lite Calprotectin Extended Range, an assay which aids in the diagnosis of Inflammatory Bowel Disease (IBD), and can help differentiate IBD from Irritable Bowel Syndrome (IBS).
PAREXEL Consulting, a business unit of PAREXEL International and leading global life sciences consultancy serving the biopharmaceutical and medical device industries, today released two new white papers from leading biosimilar experts that provide key insights into emerging areas of biosimilar development.
New preclinical work by a team of researchers from Roswell Park Comprehensive Cancer Center's Transplant and Cellular Therapy Program suggests that the risk of developing acute graft vs. host disease during allogeneic blood/marrow transplant - a potentially curative treatment for selected patients with hematologic disorders -; can be decreased using an existing class of drugs called beta adrenergic agonists.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mukti Kulkarni, MD Po Box 415348, Boston, MA 02241-5348 Ph: (508) 334-1000 | Mukti Kulkarni, MD 279 Lincoln St, Worcester, MA 01605-2120 Ph: (508) 334-1000 |
News Archive
The "demands imposed by the retirement of millions of baby boomers will consume the federal budget and blight the prospects of the next generations" without efforts to address problems with the long-term financial stability of Medicare and other entitlement programs, columnist David Broder writes in the Washington Post.
A recent paper published in the scientific journal Cell gives an unprecedented insight into the metabolic interactions that occur throughout the body over 24 hours.
Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, is pleased to announce the US Food and Drug Administration clearance of QUANTA Lite Calprotectin Extended Range, an assay which aids in the diagnosis of Inflammatory Bowel Disease (IBD), and can help differentiate IBD from Irritable Bowel Syndrome (IBS).
PAREXEL Consulting, a business unit of PAREXEL International and leading global life sciences consultancy serving the biopharmaceutical and medical device industries, today released two new white papers from leading biosimilar experts that provide key insights into emerging areas of biosimilar development.
New preclinical work by a team of researchers from Roswell Park Comprehensive Cancer Center's Transplant and Cellular Therapy Program suggests that the risk of developing acute graft vs. host disease during allogeneic blood/marrow transplant - a potentially curative treatment for selected patients with hematologic disorders -; can be decreased using an existing class of drugs called beta adrenergic agonists.
› Verified 8 days ago
Dr. Pankaj Anil Ksheersagar, M.B.B.S.,M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Worcester, MA 01605 Phone: 508-334-5571 | |
Parveen Gill, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 281 Lincoln St, Med Staff Svcs, Worcester, MA 01605 Phone: 508-334-8015 | |
Rajiv Balasuriya, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 281 Lincoln St, Medical Staff Svcs, Worcester, MA 01605 Phone: 508-334-8015 | |
Lori Dilorenzo, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Mechanic St, Attn: Damaris Diaz, Worcester, MA 01608 Phone: 508-792-5400 Fax: 508-831-0074 | |
Patricia L. Seymour, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Hospital Medicine, Worcester, MA 01605 Phone: 503-334-5571 | |
Dr. Lee A Mancini, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-5812 | |
Mrs. Isabella Anna Richard, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 926 Southbridge St Apt 17, Worcester, MA 01610 Phone: 508-353-4611 |